Paclitaxel resistance is mediated by NF‑κB on mesenchymal primary breast cancer cells-Reference-Cited by-同舟云学术

Paclitaxel resistance is mediated by NF‑κB on mesenchymal primary breast cancer cells

Published:2021-12-16 Issue:2 Volume:23 Page:
ISSN:1792-1074
Container-title:Oncology Letters
language:
Short-container-title:Oncol Lett

Author:

Esparza‑lópez José¹,Longoria Ossian²,De La Cruz‑escobar Eliseo³,Garibay‑díaz Julio³,León‑rodríguez Eucario³,Ibarra‑sánchez María¹

Affiliation:

1. Biochemistry Unit, Salvador Zubirán National Institute of Health Sciences and Nutrition, Mexico City 14080, Mexico

2. Research Support Network, National Autonomous University of Mexico‑Salvador Zubirán, National Institute of Health Sciences and Nutrition, Mexico City 14080, Mexico

3. Hematology and Oncology Department, Salvador Zubirán National Institute of Health Sciences and Nutrition, Mexico City 14080, Mexico

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Drug resistance in human cancers — Mechanisms and implications;Life Sciences;2024-09

2. Bithionol eliminates acute myeloid leukaemia stem-like cells by suppressing NF-κB signalling and inducing oxidative stress, leading to apoptosis and ferroptosis;Cell Death Discovery;2024-08-29

3. Novel Antimitotic Agent SP-1-39 Inhibits Head and Neck Squamous Cell Carcinoma;Journal of Dental Research;2024-08

4. NF-κB signaling in therapy resistance of breast cancer: Mechanisms, approaches, and challenges;Life Sciences;2024-07

5. Targeting CD73 with flavonoids inhibits cancer stem cells and increases lymphocyte infiltration in a triple-negative breast cancer mouse model;Frontiers in Immunology;2024-03-27